Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05857150 · ClinicalTrials.gov registry record
Exercise Response in Humans With Obesity
A clinical trial of Obese, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT05857150: Recruiting study of Obese, sponsored by Mayo Clinic.
NCT05857150 is a study of Obese that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 120 participants, below the 207-participant average among 27 other Obese trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05857150, a study of Obese, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to understand how chronic inflammation affects muscle function and responses to exercise.
Primary Outcome
Skeletal muscle protein synthesis will be measured from the rate of incorporation of infused amino acids measured by mass spectrometry.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Strength Test
- PROCEDURE Muscle Biopsy
- DIAGNOSTIC_TEST Treadmill Test
- DIAGNOSTIC_TEST Dual-Energy X-Ray Absorptiometry
- PROCEDURE Fat Biopsy
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2023-09-22 |
| Est. Completion | 2029-07 |
What NCT05857150 shows while recruiting
NCT05857150 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 207-participant average among 27 other Obese trials with a reported enrollment target (42% lower).
The record links to 1 condition, with Obese appearing as the primary indexed condition, and to 5 interventions - of which Strength Test is the first listed.
NCT05857150 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05857150 about?
NCT05857150 is a clinical study titled "Exercise Response in Humans With Obesity". This study is being done to understand how chronic inflammation affects muscle function and responses to exercise.
What is the current status of trial NCT05857150?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2023-09-22. Estimated completion is 2029-07.
What conditions does trial NCT05857150 study?
This clinical trial studies the following conditions: Obese.
What interventions are being tested in trial NCT05857150?
The interventions under investigation include: Strength Test (DIAGNOSTIC_TEST), Muscle Biopsy (PROCEDURE), Treadmill Test (DIAGNOSTIC_TEST), Dual-Energy X-Ray Absorptiometry (DIAGNOSTIC_TEST), Fat Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT05857150?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05857150 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obese
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05857150's enrollment target sits among peer trials
120 13th of 27 higher than 15 of 27 other Obese trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obese trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Trans-nasal Endoscopy for Bariatric Patients
RECRUITING · NA
-
Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus
RECRUITING · Phase 2
-
A Single Ascending Dose Study of HM17321 in Healthy Adult Participants
RECRUITING · Phase 1
-
Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues
RECRUITING · Early Phase 1
-
Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)
RECRUITING · Phase 2
-
Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI